Department of Biostatistics

December 7, 2023

How to get the biggest “bang” for the research “buck”

Vanderbilt researchers are developing new methods to maximize what can be learned from clinical trials and cohort studies, while maintaining their rigor and reproducibility.

By Bill Snyder
Blood clot simulation
November 10, 2023

Grant to advance prevention of hospital-acquired blood clots

A Vanderbilt team team will develop and test new clinical decision support tools to facilitate timely prevention of potentially lethal hospital-acquired blood clots, also known as venous thromboembolism.

By Paul Govern
November 8, 2023

Dandan Liu to lead the Association of Clinical and Translational Statisticians

Vanderbilt’s Dandan Liu, PhD, has been elected president of the Association of Clinical and Translational Statisticians.

By Paul Govern
October 20, 2023

Bryan Shepherd’s research to validate EHR data receives MERIT Award from the NIH

Vanderbilt’s Bryan Shepherd, PhDhas received a MERIT Award, or Method to Extend Research in Time Award, from the National Institute of Allergy and Infectious Diseases.

By Paul Govern
October 17, 2023

AI predicts blood clot risk in hospitalized children: VUMC study

An artificial intelligence tool developed at Vanderbilt accurately identified pediatric patients at high risk for blood clots in a clinical trial, with no difference in outcomes compared to a control group.

By Bill Snyder
Wesley Self, MD, MPH
October 17, 2023

How biostatistics saves lives: the Vanderbilt experience

Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.

By Bill Snyder
August 2, 2023

VUMC receives $28 million to lead national study of COVID-diabetes link

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.
By Bill Snyder
July 17, 2023

Academy for Excellence in Education elects 13 new members

Vanderbilt University Medical Center's Academy for Excellence in Education has elected 13 new members for 2023.
By Doug Campbell
February 23, 2023

Review explores ICU-related cognitive impact scores

A recent systematic review by Vanderbilt researchers has taken a close look at the cognitive instruments used in long-term outcome studies of survivors of adult critical illness and how those test scores are interpreted.
By Nancy Humphrey
January 26, 2023

VUMC establishes novel Center for Learning Healthcare

Vanderbilt University Medical Center has established a first-of-its-kind Center for Learning Healthcare that will bring together clinicians, health system operations leaders and researchers to generate evidence in the course of health care delivery to continuously improve the quality, value and safety of health care offered to patients.
By Nancy Humphrey
November 30, 2022

Study links excess oxygen during anesthesia to risk of organ injury

A Vanderbilt study found that higher levels of excess oxygen given to patients under general anesthesia add risk of injury to the kidneys, lungs and heart.
By Paul Govern
July 28, 2022

Specialty pharmacists help reduce MS relapse risk

Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse.
By Joshua Baker
July 21, 2022

Epidemiology PhD program receives CEPH accreditation

The Vanderbilt Epidemiology PhD Program has received accreditation from the Council on Education for Public Health (CEPH).
By Leigh MacMillan